Latest & greatest articles for cerebral palsy

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on cerebral palsy or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on cerebral palsy and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for cerebral palsy

42. Gait analysis in children with cerebral palsy Full Text available with Trip Pro

Gait analysis in children with cerebral palsy Cerebral palsy (CP) children present complex and heterogeneous motor disorders that cause gait deviations.Clinical gait analysis (CGA) is needed to identify, understand and support the management of gait deviations in CP. CGA assesses a large amount of quantitative data concerning patients' gait characteristics, such as video, kinematics, kinetics, electromyography and plantar pressure data.Common gait deviations in CP can be grouped into the gait (...) objective identification of gait deviations and further the understanding of gait deviations. Numerous treatment options are available to manage gait deviations in CP. Generally, treatments strive to limit secondary deformations, re-establish the lever arm function and preserve muscle strength.Additional roles of CGA are to better understand the effects of treatments on gait deviations. Cite this article: Armand S, Decoulon G, Bonnefoy-Mazure A. Gait analysis in children with cerebral palsy. EFORT Open

2016 EFORT open reviews

43. Dance Improves Functionality and Psychosocial Adjustment in Cerebral Palsy: A Randomized Controlled Clinical Trial. (Abstract)

Dance Improves Functionality and Psychosocial Adjustment in Cerebral Palsy: A Randomized Controlled Clinical Trial. This randomized controlled clinical trial aimed to investigate the effect of dance in the functionality and psychosocial adjustment of young subjects with cerebral palsy (CP).Twenty-six young subjects with CP, GMFCS (Gross Motor Function Classification System) levels from II to V, were randomized into two intervention groups: kinesiotherapy and dance (n = 13 each). Twenty-four (...) emotional and social aspects, supporting the concept of complex multimodal psychomotor adjustments. Dance promoted enhancement on functionality and social activities regarding psychosocial adjustments in cerebral palsy young subjects.

2016 American journal of physical medicine & rehabilitation Controlled trial quality: uncertain

44. Sialanar (glycopyrronium) - for treating severe drooling of saliva in children and adolescents (aged 3 years and above) with conditions affecting the nervous system, such as cerebral palsy, epilepsy and neurodegenerative diseases

Sialanar (glycopyrronium) - for treating severe drooling of saliva in children and adolescents (aged 3 years and above) with conditions affecting the nervous system, such as cerebral palsy, epilepsy and neurodegenerative diseases 30 Churchill Place ? Canary Wharf ? London E14 5EU ? United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5520 Send a question via our website www.ema.europa.eu/contact 21 July 2016 EMA/555265/2016 Committee (...) Pharmacopoeia or blood pressure bpm beats per minute CE Conformité Européene CEP Certificate of Suitability of the Ph.Eur. CHMP Committee for Medicinal Products for Human Use CHO chinese hamster ovary C max maximum concentration in plasma (or serum) CI confidence interval Cl (total plasma) clearance CMS Concerned Member State CNS central nervous system CoA Certificate of Analysis CP cerebral palsy CRS Chemical Reference Substance (official standard) CSF cerebrospinal fluid CSR clinical study report %CV

2016 European Medicines Agency - EPARs

45. Randomized Controlled Trial on Effectiveness of Intermittent Serial Casting on Spastic Equinus Foot in Children with Cerebral Palsy After Botulinum Toxin-A Treatment. (Abstract)

Randomized Controlled Trial on Effectiveness of Intermittent Serial Casting on Spastic Equinus Foot in Children with Cerebral Palsy After Botulinum Toxin-A Treatment. Physical therapy (PT) and botulinum toxin-A (BTX-A) injections are widely used in the treatment of spastic equinus foot due to cerebral palsy. The aim of this study was to show effects of intermittent serial casting (SC) in addition to standard treatment on spasticity, passive range of motion (PROM), and gait.Fifty-one ambulatory (...) foot.Complete the self-assessment activity and evaluation online at http://www.physiatry.org/JournalCME CME OBJECTIVES: Upon completion of this article, the reader should be able to: (1) identify treatment options for spastic equinus goot in children with cerebral palsy; (2) explain different approaches of serial casting with an additional model of intermittent casting; and (3) describe the potential benefits of combined treatment modalities, including intermittent serial casting, for spastic equinus foot

2016 American journal of physical medicine & rehabilitation Controlled trial quality: uncertain

46. Cerebral Palsy Integrated Pathway Scotland

Cerebral Palsy Integrated Pathway Scotland Cerebral Palsy Integrated Pathway Scotland (CPIPS) DVD | Association of Paediatric Chartered Physiotherapists Username or email address. Password Remember me Don't have an account yet? Search Breadcrumb Cerebral Palsy Integrated Pathway Scotland (CPIPS) DVD Children with cerebral palsy (CP) are at risk of developing musculoskeletal problems such as muscle contractures, displacement of the hip and scoliosis. Hip dislocation leads to pain, decreased (...) , standardised physical and radiological assessments. This, in turn, allows the early identification of hip displacement and timely intervention. Monitoring and preventing progressive hip displacement has been the main aim of established hip surveillance programmes in other countries. In Sweden and Australia the incidence of hip dislocation has significantly reduced by earlier intervention after the introduction of the surveillance programmes. Cerebral Palsy Integrated Pathway Scotland (CPIPS) has been

2016 Chartered Society of Physiotherapy

47. Using Free Internet Videogames in Upper Extremity Motor Training for Children with Cerebral Palsy. Full Text available with Trip Pro

Using Free Internet Videogames in Upper Extremity Motor Training for Children with Cerebral Palsy. Movement therapy is one type of upper extremity intervention for children with cerebral palsy (CP) to improve function. It requires high-intensity, repetitive and task-specific training. Tedium and lack of motivation are substantial barriers to completing the training. An approach to overcome these barriers is to couple the movement therapy with videogames. This investigation: (1) tested

2016 Behavioral sciences (Basel, Switzerland) Controlled trial quality: uncertain

48. Informing evidence-based clinical practice guidelines for children with cerebral palsy at risk of osteoporosis: an update Full Text available with Trip Pro

Informing evidence-based clinical practice guidelines for children with cerebral palsy at risk of osteoporosis: an update Informing evidence‐based clinical practice guidelines for children with cerebral palsy at risk of osteoporosis: an update - Ozel - 2016 - Developmental Medicine & Child Neurology - Wiley Online Library The full text of this article hosted at iucr.org is unavailable due to technical difficulties.

2016 Pediatric Endocrine Society

49. Prenatal Factors in Cerebral Palsy. Full Text available with Trip Pro

Prenatal Factors in Cerebral Palsy. 26630149 2015 12 07 2018 12 02 1533-4406 373 23 2015 12 03 The New England journal of medicine N. Engl. J. Med. Prenatal Factors in Cerebral Palsy. 2288 10.1056/NEJMc1512559 Meller César H CH Izbizky Gustavo H GH Otaño Lucas L eng Letter Comment United States N Engl J Med 0255562 0028-4793 AIM IM N Engl J Med. 2015 Sep 3;373(10):946-53 26332549 N Engl J Med. 2015 Dec 3;373(23):2288-9 26630148 Cerebral Palsy etiology Congenital Abnormalities Fetal Growth

2015 NEJM

50. Prenatal Factors in Cerebral Palsy. (Abstract)

Prenatal Factors in Cerebral Palsy. 26630148 2015 12 07 2018 12 02 1533-4406 373 23 2015 12 03 The New England journal of medicine N. Engl. J. Med. Prenatal Factors in Cerebral Palsy. 2288-9 10.1056/NEJMc1512559 Nelson Karin B KB Blair Eve E eng Letter Comment United States N Engl J Med 0255562 0028-4793 AIM IM N Engl J Med. 2015 Sep 3;373(10):946-53 26332549 N Engl J Med. 2015 Dec 3;373(23):2288 26630149 Cerebral Palsy etiology Congenital Abnormalities Fetal Growth Retardation Humans 2015 12 3

2015 NEJM

52. Safety of Botulinum Toxin Type A for Children With Nonambulatory Cerebral Palsy Full Text available with Trip Pro

Safety of Botulinum Toxin Type A for Children With Nonambulatory Cerebral Palsy To determine safety of intramuscular botulinum toxin A (BoNT-A) injections to reduce spasticity and improve care and comfort of nonambulatory children with cerebral palsy (CP).Nonambulatory children with CP were randomly allocated to receive either BoNT-A (n = 23) or sham procedure (n = 18) in Cycle 1. In Cycle 2, the BoNT-A group received a second episode of BoNT-A (n = 20) and sham group received their first

2015 EvidenceUpdates Controlled trial quality: uncertain

53. Chronic conditions in adults with cerebral palsy Full Text available with Trip Pro

Chronic conditions in adults with cerebral palsy 26624831 2016 01 04 2018 11 13 1538-3598 314 21 2015 Dec 01 JAMA JAMA Chronic Conditions in Adults With Cerebral Palsy. 2303-5 10.1001/jama.2015.11025 Peterson Mark D MD Department of Physical Medicine and Rehabilitation, University of Michigan, Ann Arbor. Ryan Jennifer M JM Brunel University London, Institute of Environment, Health and Societies, London, England. Hurvitz Edward A EA Department of Physical Medicine and Rehabilitation, University (...) of Michigan, Ann Arbor. Mahmoudi Elham E Department of Surgery, University of Michigan, Ann Arbor. eng K01 HD074706 HD NICHD NIH HHS United States 1KO1 HD074706 HD NICHD NIH HHS United States Journal Article Research Support, N.I.H., Extramural United States JAMA 7501160 0098-7484 AIM IM Adult Cerebral Palsy complications Chronic Disease epidemiology Female Health Surveys Humans Male Middle Aged Risk United States epidemiology 2015 12 2 6 0 2015 12 2 6 0 2016 1 5 6 0 ppublish 26624831 2473481 10.1001/jama

2015 JAMA

54. Intrathecal baclofen for treating spasticity in children with cerebral palsy. (Abstract)

Intrathecal baclofen for treating spasticity in children with cerebral palsy. Cerebral palsy is a disorder of movement and posture arising from a non-progressive lesion in the developing brain. Spasticity, a disorder of increased muscle tone, is the most common motor difficulty and is associated with activity limitation to varying degrees in mobility and self care.Oral baclofen, a gamma-aminobutyric acid (GABA) agonist, has been used in oral form to treat spasticity for some time, but it has (...) baclofen pumps over six months.The four short-term studies demonstrated that intrathecal baclofen therapy reduces spasticity in children with cerebral palsy. However, two of these studies utilised inappropriate techniques for statistical analysis of results. The single longer-term study demonstrated minimal reduction in spasticity with the use of intrathecal baclofen therapy.One of the short-term studies and the longer term study showed improvement in comfort and ease of care. The longer term study

2015 Cochrane

55. Active Video Gaming and Virtual Reality for Children with Cerebral Palsy: Sustained Clinical Effectiveness

Active Video Gaming and Virtual Reality for Children with Cerebral Palsy: Sustained Clinical Effectiveness Active Video Gaming and Virtual Reality for Children with Cerebral Palsy: Sustained Clinical Effectiveness | CADTH.ca Find the information you need Active Video Gaming and Virtual Reality for Children with Cerebral Palsy: Sustained Clinical Effectiveness Active Video Gaming and Virtual Reality for Children with Cerebral Palsy: Sustained Clinical Effectiveness Published on: September 10 (...) , 2015 Project Number: RB0908-000 Product Line: Research Type: Devices and Systems Report Type: Summary of Abstracts Result type: Report Question What is the long-term clinical effectiveness of active video gaming (AVG) or virtual reality (VR) for children with cerebral palsy (CP)? Key Message One systematic review, three randomized controlled trials and two non-randomized studies were identified regarding the long-term clinical effectiveness of active video-gaming (AVG) or virtual reality (VR

2015 Canadian Agency for Drugs and Technologies in Health - Rapid Review

56. Functional Electrical Stimulation (FES) for Children with Spinal Cord Injuries or Cerebral Palsy : Update of Review of Clinical Effectiveness

Functional Electrical Stimulation (FES) for Children with Spinal Cord Injuries or Cerebral Palsy : Update of Review of Clinical Effectiveness Functional Electrical Stimulation (FES) for Children with Spinal Cord Injuries or Cerebral Palsy : Update of Review of Clinical Effectiveness | CADTH.ca Find the information you need Functional Electrical Stimulation (FES) for Children with Spinal Cord Injuries or Cerebral Palsy : Update of Review of Clinical Effectiveness Functional Electrical (...) Stimulation (FES) for Children with Spinal Cord Injuries or Cerebral Palsy : Update of Review of Clinical Effectiveness Published on: August 10, 2015 Project Number: RB0896-000 Product Line: Research Type: Devices and Systems Report Type: Summary of Abstracts Result type: Report Question What is the clinical effectiveness of functional electrical stimulation (FES) including FES cycling (FES Cycle) for children with spinal cord injuries? What is the clinical effectiveness of functional electrical

2015 Canadian Agency for Drugs and Technologies in Health - Rapid Review

57. Clostridium botulinum neurotoxin type A (Xeomin) for sialorrhoea associated with adult Parkinson's disease and paediatric cerebral palsy

Clostridium botulinum neurotoxin type A (Xeomin) for sialorrhoea associated with adult Parkinson's disease and paediatric cerebral palsy Clostridium botulinum neurotoxin type A (Xeomin) for sialorrhoea associated with adult Parkinson's disease and paediatric cerebral palsy Clostridium botulinum neurotoxin type A (Xeomin) for sialorrhoea associated with adult Parkinson's disease and paediatric cerebral palsy NIHR HSRIC Record Status This is a bibliographic record of a published health technology (...) assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation NIHR HSRIC. Clostridium botulinum neurotoxin type A (Xeomin) for sialorrhoea associated with adult Parkinson's disease and paediatric cerebral palsy. Birmingham: NIHR Horizon Scanning Research&Intelligence Centre. Horizon Scanning Review. 2015 Authors' objectives Clostridium botulinum neurotoxin type A (Xeomin) is a purified botulinum toxin type A, which acts as a neuromuscular blocking agent

2015 Health Technology Assessment (HTA) Database.

58. Daily functional electrical stimulation during everyday walking activities improves performance and satisfaction in children with unilateral spastic cerebral palsy: a randomized controlled trial. Full Text available with Trip Pro

Daily functional electrical stimulation during everyday walking activities improves performance and satisfaction in children with unilateral spastic cerebral palsy: a randomized controlled trial. The aim of this paper is to determine whether daily functional electrical stimulation (FES) is effective in improving self-perceptions of individually identified mobility performance problems in children with unilateral spastic cerebral palsy (USCP). We hypothesized that children receiving 8 weeks

2015 Archives of physiotherapy Controlled trial quality: predicted high

59. Sleep positioning systems for children with cerebral palsy. Full Text available with Trip Pro

Sleep positioning systems for children with cerebral palsy. Sleep positioning systems can be prescribed for children with cerebral palsy to help reduce or prevent hip migration, provide comfort to ease pain and/or improve sleep. As sleep disturbance is common in children with developmental disabilities, with impact on their carers' sleep, and as sleep positioning systems can be expensive, guidance is needed to support decisions as to their use.To determine whether commercially-available sleep (...) positioning systems, compared with usual care, reduce or prevent hip migration in children with cerebral palsy. Any negative effect of sleep positioning systems on hip migration will be considered within this objective.Secondary objectives were to determine the effect of sleep positioning systems on: (1) number or frequency of hip problems; (2) sleep patterns and quality; (3) quality of life of the child and family; (4) pain; and (5) physical functioning. We also sought to identify any adverse effects

2015 Cochrane

60. Equine therapy and other Equine-related therapies in developmental disorders, autism spectrum disorders and cerebral palsy

Equine therapy and other Equine-related therapies in developmental disorders, autism spectrum disorders and cerebral palsy Equine therapy and other Equine-related therapies in developmental disorders, autism spectrum disorders and cerebral palsy Equine therapy and other Equine-related therapies in developmental disorders, autism spectrum disorders and cerebral palsy Oubiña M, Bardach A, Pichon-Riviere A, Augustovski F, García Martí S, Alcaraz A, Ciapponi A, López A, Rey-Ares L Record Status (...) This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Oubiña M, Bardach A, Pichon-Riviere A, Augustovski F, García Martí S, Alcaraz A, Ciapponi A, López A, Rey-Ares L. Equine therapy and other Equine-related therapies in developmental disorders, autism spectrum disorders and cerebral palsy. Buenos Aires: Institute for Clinical Effectiveness and Health Policy (IECS). Documentos de

2015 Health Technology Assessment (HTA) Database.